K Merx - UMM, Mannheim, Germany | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 26 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Mfolfox6 Versus Mfolfox6 + Aflibercept As Neoadjuvant Treatment in MRI-defined T3-rectal Cancer: a Randomized Phase-Ii-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)

R. -D. Hofheinz,F. Herrle,T. Dechow,L. F. von Weikersthal, M. Welslau, S. Lettmaier, C. Burkart, S. Kubicka, L. Kochen,K. Merx, K. Krause, M. Ebert,C. Roedel, E. Fokas,M. Ghadimi,C. Reissfelder, T. Gaiser

ESMO OPENno. 9 (2024)

引用0浏览0WOS引用

Neoadjuvant mFOLFOX6+/- Aflibercept in patients with T3-rectal cancer at low risk for local failure: a randomized phase II trial of the German Rectal Cancer Study Group (ACO/ARO/AIO 0214)

R. -D. Hofheinz,K. Merx,F. Herrle,T. Dechow,Fischer L. von Weikersthal,M. Welslau,R. Fietkau, C. Burkhart,S. Kubicka, L. Kochen, C. M. Roedel,E. Fokas,M. Ghadimi,C. Reissfelder, T. Gaiser

ONCOLOGY RESEARCH AND TREATMENT (2023): 157-157

引用0浏览0引用

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

M R Gaiser,S Lorenzen,K Merx,J Trojan,J Ocvirk,T J Ettrich,S-E Al-Batran,H Schulz,N Homann, H-P Feustel, M Schatz,M Kripp,N Schulte,S Heeger, S Vlassak, W Koch,R-D Hofheinz

Annals of oncology : official journal of the European Society for Medical Oncology（2018）

引用5浏览0WOS引用

Vitamin K1 Cream significantly reduces the Appearance and Severity of Cetuximab-induced acneiform Skin Symptoms in Women: A post-hoc Analysis of the EVITA-Study

M. R. Gaiser,S. Lorenzen,K. Merx,J. Trojan,J. Ocvirk,T. J. Ettrich,S. E. Al-Batran,N. Homann, M. Schatz,R. D. Hofheinz

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT（2018）

引用0浏览0引用

EVITA-a Double-Blind, Vehicle-Controlled, Randomized Phase II Trial of Vitamin K1 Cream As Prophylaxis for Cetuximab-Induced Skin Toxicity

R. -D. Hofheinz,S. Lorenzen,J. Trojan,J. Ocvirk,T. J. Ettrich,S. -E. Al-Batran,H. Schulz,N. Homann, H. -P. Feustel, M. Schatz,M. Kripp,N. Schulte, M. Tetyusheva,S. Heeger, S. Vlassak,K. Merx

Annals of oncology（2018）

引用18浏览0WOS引用

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase Ii Trials

M. Kripp,K. Horisberger,S. Mai,P. Kienle,T. Gaiser,S. Post,F. Wenz,K. Merx,R. -D. Hofheinz

Gastroenterology research and practice（2015）

引用15浏览0WOS引用

Use of complementary and alternative medicine: a survey among patients treated in an interdisciplinary outpatient cancer center

K. Merx, V Hodorkowski,S. Belle,N. Schulte,A. Gerhardt,W. -K Hofmann,R. -D Hofheinz,M. Kripp

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2014): 293.0-293

引用0浏览0引用

Physical activity and quality of life: a survey among cancer patients undergoing chemotherapy

M. Kripp, A. -L Heusser,N. Schulte,S. Belle,A. Gerhardt,W. -K Hofmann,R. -D Hofheinz,K. Merx

ONCOLOGY RESEARCH AND TREATMENTno. SUPnan (2014): 292.0-293

引用0浏览0引用

Capecitabine in Combination with Docetaxel and Mitomycin C in Patients with Pre-Treated Tumours: Results of an Extended Phase-I Trial

T Ernst,K Merx,U Gnad-Vogt,N Lukan,M Kripp,B Schultheis,A Hochhaus,R-D Hofheinz

British journal of cancerno. 11 (2007): 1475-1479

引用2浏览0WOSNATURE引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn